Transaction in Own Shares

Summary by AI BETAClose X

Hikma Pharmaceuticals Plc has purchased 373,615 of its own ordinary shares on 27 May 2026, 250,000 on 28 May 2026, and 373,615 on 29 May 2026, as part of its $250 million share repurchase program. These purchases were made on XLON with prices ranging from 1,462.0000 pence to 1,503.0000 pence. The company intends to cancel these repurchased shares, and following this, the total number of issued ordinary shares will be 214,437,610, with the total voting rights remaining the same.

Disclaimer*

UK 100

Latest directors dealings